| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f25d9b7e1fadfcbe0f4127cc79658aea |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 |
| filingDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_135359511ad03b557d321c9202cfb3d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746a4c829d24f0fbf5eb6c42a8445932 |
| publicationDate |
2012-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201247208-A |
| titleOfInvention |
A pharmaceutical composition for inhibiting the recurrence, progression or metastasis of liver cancer |
| abstract |
A pharmaceutical composition for inhibiting the recurrence, progression or metastasis of liver cancer is provided. The pharmaceutical composition includes at least a compound of formula (I) and a pharmaceutically acceptable carrier. |
| priorityDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |